Evidence map›Paper›PMID 29625991›Full record

ArticleDiabetes2018

T

Cristina Aguayo-Mazzucato, Terence B Lee, Michelle Matzko, Amanda DiIenno, Habib Rezanejad, Preeti Ramadoss, Thomas Scanlan, Ann Marie Zavacki, P Reed Larsen, Anthony Hollenberg and 3 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Effects of Neurogenin 3 Induction on Endocrine Differentiation and Delamination in Adult Human Pancreatic Ductal Organoids.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Cristina Aguayo-MazzucatoJoslin Diabetes Center, Harvard Medical School, Boston, MA.
Terence B LeeJoslin Diabetes Center, Harvard Medical School, Boston, MA.
Michelle MatzkoJoslin Diabetes Center, Harvard Medical School, Boston, MA.
Amanda DiIennoDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA.
Habib RezanejadJoslin Diabetes Center, Harvard Medical School, Boston, MA.
Preeti RamadossDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
Thomas ScanlanDepartment of Physiology & Pharmacology, Oregon Health & Science University, Portland, OR.
Ann Marie ZavackiThyroid Section, Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
P Reed LarsenThyroid Section, Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Anthony HollenbergDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
Clark ColtonDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA.
Arun SharmaJoslin Diabetes Center, Harvard Medical School, Boston, MA.
Susan Bonner-WeirJoslin Diabetes Center, Harvard Medical School, Boston, MA susan.bonner-weir@joslin.harvard.edu.ORCID 0000-0003-4682-0656
Joslin Diabetes Center · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USMassachusetts Institute of Technology · USOregon Health & Science University · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Thyroid Hormone ActionR01DK052798 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCANLAN, THOMAS STERLING · 1997 to 2020
$5.7M
Physiological Factors Driving Maturation of Neonatal Beta CellsR01DK093909 · NIDDK · JOSLIN DIABETES CENTER · PI BONNER-WEIR, SUSAN · 2011 to 2015
$1.8M
Aging of the beta cell and type 2 diabetesR01DK110390 · NIDDK · JOSLIN DIABETES CENTER · PI BONNER-WEIR, SUSAN · 2017 to 2020
$1.7M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK052798NIDDK NIH HHS R01 DK093909NIDDK NIH HHS R01 DK110390
6 · The paper itself

Abstract

Previously, we showed that thyroid hormone (TH) triiodothyronine (T

Indexed as

Cell DifferentiationCellular SenescenceAnimalsBiomarkersCells, CulturedCyclin-Dependent Kinase Inhibitor p16HumansInsulin-Secreting CellsMaf Transcription Factors, LargeMiceMice, Inbred C57BLRatsRats, Sprague-DawleyReceptors, Thyroid HormoneTriiodothyronineUp-RegulationBiomarkersCyclin-Dependent Kinase Inhibitor p16Mafa protein, mouseMaf Transcription Factors, LargeReceptors, Thyroid HormoneTriiodothyronine

Identifiers

PMID29625991
PMCPMC6014556
OpenAlexW2795633066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.